Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Comments on Study Comparing Outcomes in Prolapse Repair with Surgical Mesh or Native Tissue

The Firm is investigating mesh implant lawsuits on behalf of women who allegedly suffered severe vaginal mesh complications associated with products manufactured by American Medical Systems, Inc., Boston Scientific, Inc., C.R. Bard and Ethicon, Inc.

New York, NY (PRWEB) May 10, 2013

With transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuitclaims.com/) mounting in courts around the country, a new study is raising additional concerns about the risks and benefits associated with the use of surgical mesh implants in pelvic organ prolapse repair, Bernstein Liebhard LLP reports. The study, which was reported at the annual meeting of the Society of Gynecologic Surgeons, found that patient satisfaction and cure rates were similar regardless of whether mesh or native tissue was used. However, subjects treated with mesh reported more complications without experiencing benefits beyond what was seen in patients who underwent native tissue repair. Among other things, enrollment in the study was halted due to a mesh erosion rate that exceeded 15%.*

“We are representing numerous women who have allegedly suffered serious vaginal mesh complications, including mesh erosion into vaginal tissue. This study further confirms that transvaginal repair of pelvic organ prolapse with surgical mesh may carry substantial risks compared to alternate procedures,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing hundreds of women in mesh implant lawsuits who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to transvaginal mesh products marketed by American Medical Systems, Inc., Boston Scientific, Inc., C.R. Bard and Ethicon, Inc.

Transvaginal Mesh Lawsuits
Transvaginal mesh has been the subject of growing safety concerns since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious transvaginal mesh side effects over a three year period. In July 2011, the FDA warned that there had been a five-fold increase in reports of serious complications associated with the use of pelvic mesh in prolapse repair since its previous alert. The agency also modified the position it had taken in 2008 regarding frequency vaginal mesh complications, stating in the alert that these injuries were not rare.**

Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees for several multidistrict litigations established in U.S. District Court, Southern District of West Virginia for mesh implant lawsuits, including: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”).

Mr. Grand is also serving as Co-Liaison Counsel in two consolidated litigations underway in New Jersey’s Atlantic County Superior Court for transvaginal mesh lawsuits involving Ethicon and C.R. Bard products. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10) In March, the nation’s first trial involving an Ethicon product concluded in the New Jersey litigation, with the jury awarding more than $11 million to the Plaintiff. Mr. Grand was also member of the trial team. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey)

Victims of alleged vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. More Information regarding mesh implant lawsuits can be found at Bernstein Liebhard's website. To arrange for a free case evaluation, please call 1-877-779-1414.

*OBGYN News, May 9, 2013; http://www.obgynnews.com/news/top-news/single-article/mesh-native-tissue-for-prolapse-repair-yield-similar-3-year-outcomes/3c04dfc41a59850a98083d8c7dac7aa3.html
**fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.transvaginalmeshlawsuitclaims.com/